Roxanne Gal

852 total citations
26 papers, 442 citations indexed

About

Roxanne Gal is a scholar working on Oncology, Surgery and Pathology and Forensic Medicine. According to data from OpenAlex, Roxanne Gal has authored 26 papers receiving a total of 442 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 12 papers in Surgery and 7 papers in Pathology and Forensic Medicine. Recurrent topics in Roxanne Gal's work include Management of metastatic bone disease (12 papers), Cancer survivorship and care (8 papers) and Spine and Intervertebral Disc Pathology (7 papers). Roxanne Gal is often cited by papers focused on Management of metastatic bone disease (12 papers), Cancer survivorship and care (8 papers) and Spine and Intervertebral Disc Pathology (7 papers). Roxanne Gal collaborates with scholars based in Netherlands, Canada and United Kingdom. Roxanne Gal's co-authors include Evelyn M. Monninkhof, Anne M. May, Monique Simons, Helena M. Verkooijen, Joanne M. van der Velden, Carla H. van Gils, Petra H.M. Peeters, Jorrit‐Jan Verlaan, N. Kasperts and Rolf H. H. Groenwold and has published in prestigious journals such as Journal of Clinical Epidemiology, International Journal of Radiation Oncology*Biology*Physics and Radiotherapy and Oncology.

In The Last Decade

Roxanne Gal

21 papers receiving 439 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Roxanne Gal Netherlands	11	141	134	125	95	91	26	442
Angela Laffan United States	9	157 1.1×	108 0.8×	93 0.7×	41 0.4×	50 0.5×	22	456
Jason Tan Australia	13	149 1.1×	74 0.6×	86 0.7×	104 1.1×	142 1.6×	23	805
Marcus Vaska Canada	12	148 1.0×	87 0.6×	113 0.9×	35 0.4×	109 1.2×	51	488
Deborah Vollmer Dahlke United States	10	124 0.9×	29 0.2×	119 1.0×	32 0.3×	153 1.7×	21	513
Karoliina Karjalainen Finland	16	57 0.4×	64 0.5×	64 0.5×	80 0.8×	78 0.9×	60	558
Stephen Caswell United Kingdom	12	219 1.6×	148 1.1×	52 0.4×	24 0.3×	125 1.4×	19	438
Yvonne L. Eaglehouse United States	13	168 1.2×	79 0.6×	75 0.6×	30 0.3×	84 0.9×	36	435
Philippe Laramée France	14	185 1.3×	36 0.3×	88 0.7×	230 2.4×	49 0.5×	36	689
Lisa M. Wintner Austria	15	383 2.7×	62 0.5×	95 0.8×	85 0.9×	182 2.0×	38	739
Aomei Shen China	12	224 1.6×	65 0.5×	36 0.3×	48 0.5×	34 0.4×	32	368

Countries citing papers authored by Roxanne Gal

Since Specialization

Citations

This map shows the geographic impact of Roxanne Gal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roxanne Gal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roxanne Gal more than expected).

Fields of papers citing papers by Roxanne Gal

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roxanne Gal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roxanne Gal. The network helps show where Roxanne Gal may publish in the future.

Co-authorship network of co-authors of Roxanne Gal

This figure shows the co-authorship network connecting the top 25 collaborators of Roxanne Gal. A scholar is included among the top collaborators of Roxanne Gal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roxanne Gal. Roxanne Gal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gal, Roxanne, Wietse S.C. Eppinga, Helena M. Verkooijen, et al.. (2025). Risk Factors for the Development of Neurological Deficits in Metastatic Spinal Disease: An International, Multicenter Delphi Study. Global Spine Journal. 15(1_suppl). 93S–103S.

Verlaan, Jorrit‐Jan, N. Kasperts, Wietse S.C. Eppinga, et al.. (2025). Pain response of patients treated with radiotherapy for painful bone metastases between 2013 and 2024 – An analysis of the prospective real-world PRESENT cohort. Radiotherapy and Oncology. 214. 111263–111263.

Mercier, Carole, Roxanne Gal, Jorrit‐Jan Verlaan, et al.. (2024). Stereotactic Body and Conventional Radiotherapy for Painful Bone Metastases. JAMA Network Open. 7(2). e2355409–e2355409. 14 indexed citations

Atsma, Femke, Marilot C. T. Batenburg, Hanneke Meijer, et al.. (2024). Competing risk analysis of cardiovascular disease risk in breast cancer patients receiving a radiation boost. Cardio-Oncology. 10(1). 7–7. 1 indexed citations

Stuiver, Martijn M., Caroline S. Kampshoff, Rosalie J. Huijsmans, et al.. (2023). Translating Evidence from Dutch Exercise Oncology Trials in Patients with Breast Cancer into Clinical Practice Using the RE-AIM Framework. European Journal of Cancer Care. 2023. 1–18.

Velden, Joanne M. van der, N. Kasperts, Janneke P.C. Grutters, et al.. (2023). Stereotactic Body radiotherapy and pedicLE screw fixatioN During one hospital visit for patients with symptomatic unstable spinal metastases: a randomized trial (BLEND RCT) using the Trials within Cohorts (TwiCs) design. Trials. 24(1). 307–307. 3 indexed citations

Gal, Roxanne, Raphaële Charest-Morin, Jorrit‐Jan Verlaan, et al.. (2022). Patient Expectations About Palliative Treatment for Symptomatic Spinal Metastases: A Qualitative Study. Value in Health. 26(1). 4–9. 1 indexed citations

Gal, Roxanne, N. Kasperts, Joost J.C. Verhoeff, et al.. (2022). Quality of Life After Stereotactic Body Radiation Therapy Versus Conventional Radiation Therapy in Patients With Bone Metastases. International Journal of Radiation Oncology*Biology*Physics. 112(5). 1203–1215. 9 indexed citations

Gal, Roxanne, Evelyn M. Monninkhof, Carla H. van Gils, et al.. (2021). Effects of exercise in breast cancer patients: implications of the trials within cohorts (TwiCs) design in the UMBRELLA Fit trial. Breast Cancer Research and Treatment. 190(1). 89–101. 23 indexed citations

10.

Velzen, Sanne G. M. van, Roxanne Gal, Arco J. Teske, et al.. (2021). AI-Based Radiation Dose Quantification for Estimation of Heart Disease Risk in Breast Cancer Survivors After Radiation Therapy. International Journal of Radiation Oncology*Biology*Physics. 112(3). 621–632. 14 indexed citations

11.

Gal, Roxanne, Marleen J. Emaus, Erwin L. A. Blezer, et al.. (2021). Coronary artery calcifications on breast cancer radiotherapy planning CT scans and cardiovascular risk: What do patients want to know?. International Journal of Cardiology Cardiovascular Risk and Prevention. 11. 200113–200113. 2 indexed citations

12.

Gal, Roxanne, et al.. (2021). Impact of the COVID-19 pandemic on quality of life and emotional wellbeing in patients with bone metastases treated with radiotherapy: a prospective cohort study. Clinical & Experimental Metastasis. 38(2). 209–217. 19 indexed citations

13.

Bargon, Claudia A., Marilot C. T. Batenburg, Roxanne Gal, et al.. (2021). (Ex-)breast cancer patients with (pre-existing) symptoms of anxiety and/or depression experience higher barriers to contact health care providers during the COVID-19 pandemic. Breast Cancer Research and Treatment. 186(2). 577–583. 12 indexed citations

14.

Gal, Roxanne, Hester Wessels, Jorrit‐Jan Verlaan, et al.. (2020). Pre-treatment expectations of patients with spinal metastases: what do we know and what can we learn from other disciplines? A systematic review of qualitative studies. BMC Cancer. 20(1). 1212–1212. 9 indexed citations

15.

Velden, Joanne M. van der, Yvette M. van der Linden, N. Kasperts, et al.. (2020). Pain Response After Stereotactic Body Radiation Therapy Versus Conventional Radiation Therapy in Patients With Bone Metastases—A Phase 2 Randomized Controlled Trial Within a Prospective Cohort. International Journal of Radiation Oncology*Biology*Physics. 110(2). 358–367. 52 indexed citations

16.

Gal, Roxanne, Evelyn M. Monninkhof, Petra H.M. Peeters, et al.. (2019). Physical activity levels of women with breast cancer during and after treatment, a comparison with the Dutch female population. Acta Oncologica. 58(5). 673–681. 25 indexed citations

17.

Gal, Roxanne, Evelyn M. Monninkhof, Carla H. van Gils, et al.. (2019). The Trials within Cohorts design faced methodological advantages and disadvantages in the exercise oncology setting. Journal of Clinical Epidemiology. 113. 137–146. 30 indexed citations

18.

Gal, Roxanne, et al.. (2018). Breast Cancer Survivors’ Experiences With an Activity Tracker Integrated Into a Supervised Exercise Program: Qualitative Study. JMIR mhealth and uhealth. 7(2). e10820–e10820. 21 indexed citations

19.

Gal, Roxanne, Evelyn M. Monninkhof, Rolf H. H. Groenwold, et al.. (2017). The effects of exercise on the quality of life of patients with breast cancer (the UMBRELLA Fit study): study protocol for a randomized controlled trial. Trials. 18(1). 504–504. 14 indexed citations

20.

Figer, Arié, Evgeny Sadikov, Moshe Mishaeli, et al.. (2000). A Comparison of Two Dose Regimens in Pancreatic Cancer. Journal of Chemotherapy. 12(5). 442–445.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact